Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 950-955, May 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kwan, S.-W.
Right arrow Articles by Mandel, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwan, S.-W.
Right arrow Articles by Mandel, H. G.

The Incorporation of 6-Thioguanine into RNA Fractions and Its Effect on RNA and Protein Biosynthesis in Mouse Sarcoma 180 Ascites Cells1

Sau-Wah Kwan2, Sau-Ping Kwan3 and H. George Mandel4

Department of Pharmacology, The George Washington University School of Medicine, Washington, D. C. 20005

We examined the incorporation of 6-thioguanine into the RNA of Sarcoma 180 to determine the relative distribution of this drug in the various RNA fractions.

6-Thioguanine-35S was recovered from ribosomal RNA, transfer RNA, and rapidly labeled RNA (probably messenger RNA) as the intact compound. The incorporation of the analog into microsomal RNA was inhibited by actinomycin D and was enhanced by azaserine.

6-Thioguanine caused an immediate decrease of uridine labeling of the cytoplasmic ribosomal RNA and transfer RNA; at the same time, protein biosynthesis was inhibited. Maximal inhibition was observed 3 to 4 hr after the administration of the base analog. No inhibition of uridine labeling of the rapidly labeled cytoplasmic RNA was evident until 3 hr after drug treatment. The possible role of macromolecular effects of thioguanine on growth inhibition is discussed.

1 This work was supported by USPHS Research Grant CA 02978 from the National Cancer Institute, NIH, Bethesda, Md. 20014.

2 Present address: Department of Biochemistry and Pharmacology, Tufts University School of Medicine, Boston, Mass. 02111.

3 Present address: Department of Biological Chemistry, University of Cincinnati, College of Medicine, Cincinnati, Ohio 45219.

4 To whom reprint requests should be sent.

Received 5/18/72. Accepted 1/29/73.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
R. Brem, F. Li, and P. Karran
Reactive oxygen species generated by thiopurine/UVA cause irreparable transcription-blocking DNA lesions
Nucleic Acids Res., April 1, 2009; 37(6): 1951 - 1961.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.